PCN21 - Indirect Comparison Analysis to Evaluate the Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus Other Treatments for HER2-Positive Metastatic Breast Cancer (MBC)

Autor: Benito Garcia, E., Hersberger, V., Takyar, S., Moser, A.
Zdroj: In Value in Health November 2013 16(7):A395-A395
Databáze: ScienceDirect